Read More Pharma Industry News Why updated TRUST-I and TRUST-II results make IBTROZI a top contender in targeted lung cancer therapy Nuvation Bio unveils pivotal TRUST-I and TRUST-II updates for IBTROZI in ROS1+ lung cancer, showing strong durability and brain response. Read more now. byPallavi MadhirajuSeptember 7, 2025